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Abstract  
Introduction: tuberculosis (TB) remains a public health problem and is driven by HIV. Recent studies indicate that anti-retroviral therapy (ART) 
initiated during the first two months of anti-TB treatment (ATT) reduces risk of HIV morbidity and mortality. In Sanyati district, 14% of TB/HIV co-
infected patients were initiated on ART during TB treatment, in 2010. The study was conducted to determine the magnitude and determinants of 
delay in ART initiation, in TB/HIV co-infected patients. Methods: an analytic cross sectional study was conducted at three study sites in Sanyati 
district. The outcome was delayed ART initiation, being failure to be initiated on ART during the first two months of ATT. Respondents were 
interviewed using pre-tested questionnaires. Epi-InfoTM was used to generate frequencies, means, odds ratios and 95% confidence intervals. 
Stratified and logistic regression analysis was done. Results: of the 186 respondents, 63% had delayed ART initiation. Median delay from initiation 
of ATT to ART was 48 days (Q1=20; Q3=82). Risk factors for delayed ART initiation were: being treated for TB first time, AOR=2.23 (p=0.03); 
initially registered for HIV care outside Sanyati, AOR=3.08 (p<0.01); staying more than 5km from a clinic, AOR=3.29 (p<0.01). Enabling factors 
for early ART initiation was having a family member on ART, AOR=0.23 (p<0.01). Conclusion: significant delay and barriers to ART initiation 
were identified. Decentralization of ART initiation should be expedited. ART initiation should be expedited in patients with identified risk factors for 
delaying ART initiation. Peer support should be strengthened in families and community. Periodic evaluation of magnitude of delay and impact of 
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Tuberculosis (TB) remains a challenge to global public health. It has 
been difficult to control in areas with a high prevalence of human 
immunodeficiency virus (HIV) infection [1]. Globally, 1.1 million of 
the 8.8 million new cases of TB reported in 2012 were HIV positive. 
Of the 1.4 million TB deaths, 350,000 were HIV associated [1, 2]. 
Worldwide, 11 million people living with HIV (PLHIV) are co-infected 
with TB. The risk of developing active TB in PLHIV is 21 to 34 times 
compared to persons without HIV [2]. Approximately 82% of 
patients with TB/HIV co-infection live in sub-Saharan Africa. The 
Southern African region, including Zimbabwe, has generalized HIV 
epidemics. The HIV prevalence exceeds 50% in new TB patients [1, 
3, 4]. Since 1993, the directly observed therapy short-course 
(DOTS) strategy has been the key public health intervention used to 
control TB. The strategy focused on TB case management of 
sputum smear-positive cases with use of short-course Rifampicin-
containing chemotherapy. The DOTS strategy has been effective in 
most regions of the world. However, it has been comparatively 
ineffective in countries with a high prevalence of HIV infection [5]. 
The WHO and the Stop-TB Partnership has published guidelines, a 
strategic framework, and an interim policy in response to the 
TB/HIV challenge [5-7]. Strategies to reduce the burden of TB in 
HIV-infected persons include Isoniazid preventive therapy (IPT), 
intensified case finding, and infection control. Strategies to reduce 
the burden of HIV in patients with TB include provision of: HIV 
testing and counseling; HIV prevention services; cotrimoxazole 
prophylaxis (CPT); antiretroviral therapy (ART) and; care and 
support services [5-7]. Zimbabwe has published guidelines for the 
management of TB/HIV co-infection, based on WHO guidelines [8].  
  
In 2010, 34% of TB patients (2.1 million) were tested for HIV and 
accessed HIV prevention, treatment and care services, globally. For 
TB/HIV co-infected patients, 77% and 46% were enrolled on CPT 
and ART, respectively [1, 2]. Mathematical modeling suggests that a 
combination of high levels of ART coverage and early ART initiation 
at high CD4 cell counts may be required to significantly affect 
population TB control, especially in settings where TB and HIV 
infection are hyper endemic [9]. Many studies have shown that 
delayed initiation of ART in TB/HIV co-infected patients is associated 
with increased HIV related morbidity and mortality. Zachariah R, et 
al, in Thyolo district, Malawi, in 2007, and Joshua T. Schiffer, et al, 
in the United Kingdom, in 2007 demonstrated that ART initiated 
during the first two months of TB treatment reduced mortality [10, 
11]. Sanyati is a district in Mashonaland West Province, Zimbabwe, 
with 180,000 inhabitants. Approximately 100,000 people reside in 
Kadoma City, with the remainder staying in rural, farming and 
mining settings. There are two public hospitals, Kadoma General 
Hospital, and Sanyati Mission Hospital, in urban and rural areas, 
respectively. The hospitals are supported by 13 public clinics. The 
Zimbabwe National TB Control Program (NTP) targeted to have 
100% of TB/HIV co-infected patients on CPT, and 60% on ART 
during anti-TB treatment (ATT), for the 2010 cohorts [12]. For the 
first three quarterly TB treatment cohorts of 2010, 39%, 36% and 
14% of TB/HIV co-infected patents were commenced on ART during 
ATT nationally, in Mashonaland West Province, and in Sanyati 
district, respectively. This is despite efforts to improve access to 
ART through mobile clinics ART clinics, training of health workers in 
TB/HIV care, availing treatment guidelines, consistent supply of 
Efavirenz based ART, and strengthened supportive supervision. The 
objective of this study was to assess the magnitude and 






An analytic cross sectional study was conducted in Sanyati district, 
Mashonaland West Province, Zimbabwe. The study sites were 
TB/HIV clinics at Kadoma General Hospital, Sanyati Mission Hospital, 
and Rimuka Clinic. The study was conducted among TB patients 
with a confirmed diagnosis of HIV. Patients co-infected with TB and 
HIV: who had completed the first two months of ATT; who were 
initiated on ATT in Sanyati district and; willing to participate, were 
recruited into the study. Patients co-infected with TB/HIV: who had 
not yet completed the first two months of ATT; who developed TB 
whilst on ART; who were initiated ART and ATT outside Sanyati 
district and; not willing to participate in the study, were excluded 
from the study. Epi InfoTM7 was used to calculate the sample size. 
Assuming that 14% of TB/HIV co-infected patients had been 
commenced on ART during TB treatment in Sanyati district, a 
minimum sample size of 185 was calculated. The three study sites 
were purposively selected from the 15 health facilities in the district, 
as they had TB/HIV clinics. Based on district notification 
information, a minimum of 109(59%), 52 (28%), and 24(13%) 
were to be recruited from Rimuka clinic, Kadoma General Hospital, 
and Sanyati Mission Hospital, respectively. Convenient sampling was 
used to recruit patients as they came for reviews. Data were 
collected using a pre-tested, interviewer administered questionnaire. 
Patient treatment records were reviewed. Delay was calculated in 
days and was defined as failure to be commenced on ART during 
the first 2 months of TB treatment, in a TB/HIV co-infected patient. 
Distance to health facility was measured by estimating the distance 
of the shortest route from the respondents' home, to the health 
facility. The cost of transport was obtained by asking the most 
frequently paid amount, in American dollars, from the respondents' 
home, to ART initiation site, two ways. Key informant interviews 
were conducted on district TB/HIV program managers, using a 
discussion guide. The data collected were entered into Epi InfoTM7 
(CDC 2012). The same package was used to generate frequencies, 
means, proportions, prevalence odds ratios (POR). Tests for 
statistical significance were done at 5% level. Stratified analysis and 
stepwise forward logistic regression were done to check for effect 
modification and control for confounding. Permission to conduct the 
study was obtained from the local health authorities. Ethical 
approval was obtained from the Medical Research Council of 
Zimbabwe (MRCZ/B/347). Respondents found not on ART were 





Key informant interviews indicated that all the 15 health facilities in 
Sanyati district were providing HIV testing, and counseling for 
prevention of maternal to child transmission of HIV (PMTCT) 
prophylaxis. ART counseling and initiation was being provided at the 
two hospitals. CD4 testing for TB/HIV patients was being done at 
the 2 hospitals, and clients were charged US$4.00 per test. Figure 
1 shows the services that are available for TB/HIV patients, in 
Sanyati district. One hundred and eighty six respondents were 
recruited into the study. The respondents were recruited from the 
study sites as follows: Kadoma Hospital (65%); Rimuka Clinic (20%) 
and; Sanyati Hospital (15%). The respondents resided in urban 
(55%), rural (30%), farm (8%) and, mine (7%) settings. Fifty 
percent of the respondents had initially sought TB/HIV care in public 
hospitals or clinics. Faith healers (18%), private clinician (17%), 
traditional healer (6%), herbalist (8%), and pharmacist (1%), were 
the non public service providers initially visited for TB/HIV care. In 
terms of TB treatment supervisors, 66% mentioned family member 
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and 31% did not have. The remaining 3% were supervised by 
community and health centre health workers. Sixty-three percent of 
the respondents had delayed ART initiation. Table 1 summarizes 
the delays in processes leading to ART initiation. The overall median 
delay between ATT initiation and ART initiation was 48 days 
(Q1==20; Q3==82). The most delays occurred between HIV testing 
and first ART counseling (median=19 days, Q1=7; Q3=56), and 
between completing ART counseling and ART initiation (median=13 
days, Q1==0; Q3==28). Table 2 summarizes the factors associated 
with delayed ART initiation in Sanyati district. Patient related factors 
significantly associated with delayed ART initiation were: staying 
alone at TB diagnosis (POR=2.84, p=0.01); being a support group 
member (POR=0.35, p=0.02) and; having a family member on ART 
(POR=0.24, p=0.00). Service related determinants of delayed ART 
initiation were: fears of ART drug toxicity (POR=2.19, p=0.03); 
being treated for TB first time (POR=2.23, p=0.05); having had a 
CD4 test done (POR=0.24, p=0.00); initially registered for HIV care 
outside Sanyati (POR=2.95, p=0.01); initially sought TB/HIV care 
outside public health sector (POR=2.88, p=0.001); staying more 
than 5 kilometers from health facility (POR=3.51, p=0.002); cost to 
reach ART initiating site more than US$1 (POR=1.91, p=0.05). On 
stratified analysis, the type of TB modified the effect of having a 
CD4 test on delayed ART initiation. EPTB patients who had a CD4 
test delayed ART initiation (OR= 2.8, p=0.84). PTB patients who 
had a CD4 test initiated ART early (OR=0.18, p=0.001), (Chi square 
for differing OR's =3.98, p=0.046). Independent determinants of 
delayed ART initiation were: being treated for TB first time 
(AOR=2.23, p=0.03); initially registered for HIV care outside 
Sanyati district (AOR=3.08, p=0.01); staying more than 5 
kilometers from a health facility (AOR=3.29, p=0.01) and: having a 





In this study the overall delay from initiation of TB treatment to 
initiation of ART was 48 days. This is shorter than the 67 days delay 
reported by Gandhi N R, et al, in Sizonq´oba, KwaZulu-Natal, and 
the 81 days reported in Harare by Dimairo M, et al, in 2007 [13, 
14]. In Sanyati district, the investments in TB/HIV care might be 
bearing fruit. However, patient and health system factors may differ 
between settings. The median delay of 48 days in this study may be 
an under estimation, as this had been calculated only for 63% of 
the respondents who had been initiated on ART. The delay in ART 
initiation is attributed mainly to the delay from HIV testing to 
initiation of ART counseling (median=19 days) and the delay from 
completion of ART to initiation of ART by the doctors (median 
delay=13days). Delay maybe attributed to high ART preparation 
workload at the two hospitals, as peripheral clinics do not provide 
ART counseling. Further, only the doctors, in short supply, initiate 
ART. This is consistent with findings in South Africa by Loveday M, 
et al, in 2011, who reported that shortage of skilled health 
professionals affects success of TB/HIV care [15]. The main 
challenge identified in the same study was the policy in use, where 
only doctors, sometimes not available, initiated ART. In Sanyati 
district, nurses at peripheral clinics provided PMTCT counseling and 
ART prophylaxis. This is an opportunity to empower clinic nurses 
with skills that facilitate decentralization of ART initiation. The 
availability of psychosocial support and personal experience in 
TB/HIV care was protective against delaying ART initiation. Having a 
family member on ART or being a support group member allows 
sharing of beneficial experience from ART. This may encourage 
patients to seek HIV care early. In this study, having a treatment 
supporter was protective. However, the benefit was not statistically 
significant. This maybe so as the majority (66%) of the respondents 
had untrained family members as treatment supporters. These 
untrained family members may not be able to pass the message of 
the benefit of ART to the TB/HIV clients. Patients who had a CD4 
test done, and CD4 count being less than 350 were found to be 
initiated on ART earlier. This is consistent with the WHO TB/HIV 
guidelines, where clients with a CD4 count less than 350 should be 
commenced on ART between two weeks and two months of TB 
treatment [6, 8]. On stratified analysis, the protective effect of 
having a CD4 test was beneficial to PTB patients, HIV stage 3 
diseases. For respondents being treated for EPTB, stage 4 disease, 
having a CD4 count delayed ART initiation. This contrasts with the 
WHO recommendations, where clients suffering from EPTB should 
be immediately commenced on ART regardless of having a CD4 
result [6, 8]. Further, clients without a CD4 test result are likely to 
delay, as they have to pay US$4 for the test. Some patients may not 
afford, considering other non medical costs, such as transport.  
  
Respondents who feared ART drug toxicity were more likely to delay 
ART initiation. Similar results were reported by Kumwenda M, et al, 
in Malawi, 2011, who reported fear of ART drug toxicities and 
interactions as barriers to ART uptake in TB/HIV co-infected patients 
[16]. Drug toxicities overlap with those due to TB drugs, and 
cotrimoxazole, thus the recommended systematic introduction of 
medications [6, 10]. Potential drug toxicities and the benefits of ART 
that outweigh potential toxicities should be emphasized during ART 
preparation sessions. Further, having a relative on ART, and being 
members of support groups, may help alleviate the fears of ART 
drug toxicity. Respondents who suffered a serious illness were likely 
to initiate ART earlier, even though the association was not 
statistically significant. This is plausible, as the patients are likely to 
have more contact with the ART initiation hospitals. Further, this 
could be an indicator of health workers being more compliant in 
early initiation of ART, to prevent further serious illness. However, 
the association was not statistically significant, and may have been 
underestimated due to differences in perception of severity of illness 
by respondents. Even though most TB/HIV services are for free, 
efforts to access the centralized ART services, such as cost and 
distance to reach ART site contributed to delayed ART initiation. 
However, the distance to reach the ART initiation site was not 
statistically significant risk factor. This is consistent with findings by 
Zachariah R, et al, in Thyolo district, Malawi, in 2004, who reported 
that individuals who had to pay over US$1.00 were not likely to 
start ART [17]. The trend could be explained by some patients 
putting up at relatives' and friends' places staying near the ART 
initiation site for preparatory sessions. The association between time 
and distance with ART delay may also be distorted by variations in 
estimations, whereas the transport cost is usually reported as a 
definite value. Thus, efforts to decentralize ART initiation to the 
peripheral clinics, closer to the patients, may reduce delay. 
Respondents who stay more than 5 kilometers from a clinic were 
likely to delay ART initiation. Even though the clinics are not ART 
initiation sites, however, they provide information on available 
services, and HIV testing. Hence, those staying further from clinics 
may need to be reached through innovative measures. This 
demonstrates a potential gap in information dissemination on 
TB/HIV care. Thus, innovations, such as use of peer education by 
support group members, and family members already benefiting 
from ART may need to be put in place. Clients who initially sought 
TB/HIV care from outside the public health sector were more likely 
to delay ART. Similarly, in Zambia, Needham D M, et al, 2001, in a 
study to determine factors associated with delay in TB diagnosis 
identified having visited private doctor or traditional healer as being 
a risk factor for TB diagnostic delay [18]. Further, respondents who 
had initially sought care outside the district delayed ART initiation. 
Both scenarios demonstrate potential gaps in linkages between 
service providers, as clients lose time whilst moving places. The 
study findings may not be generalized to other settings outside 
Sanyati district. The study design may not have addressed 
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In this study, delay in ART initiation was significant. Patient and 
service related barriers to ART initiation were identified. The benefit 
of peer support amongst patients is demonstrated. Health workers 
should expedite ART preparation for patients with the identified 
risks of delay. This can be achieved by reducing the number of ART 
preparatory visits, and then strengthen counseling during 
subsequent visits. Emphasis on the benefits of ART that outweigh 
drug toxicities should be made. TB/HIV patients should be referred 
to existing support groups for PLHIV. TB/HIV patients who benefited 
on ART should be used in the families and community to increase 
awareness on processes in ART and benefits. The health managers 
should consider reducing the cost of CD4 test, whilst exempting 
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Table 1: delays in Processes Leading to Initiation of ART, Sanyati, 2011-12 
Process 
(number completed process) 
Median Delay (Days) Q1; Q3 (Days) 
Start TB treatment to HIV Testing (186) -1 -19; 3 
HIV Testing to Initiation of ART Counseling (169) 19 7; 56 
Initiation to completion of ART Counseling (166) 6 3; 15 
Completing ART Counseling to Initiation of ART (n=118) 13 0; 28 







Table 2: determinants of Delayed ART Initiation, Sanyati, 2011-12 
Variable Delayed ART Initiation POR p value 




    
Stayed alone at TB diagnosis 38(33) 10(15) 2.84 0.01 
Support group member 12(10) 17(25) 0.35 0.02 
Family member on ART 40(34) 47(68) 0.24 0.00 
Female sex 59(50) 37(54) 0.88 0.79 
Urban Residence 60(51) 43(62) 0.64 0.19 
Disclosed TB/HIV disease 108(92) 67(97) 0.34 0.31 
Perceived stigma community 48(41) 23(33) 1.39 0.38 
Perceived Health System Stigma 19(16) 11(16) 1.02 0.88 
Feared ART drug toxicity 51(44) 18(26) 2.19 0.03 
Treated TB 1st time 16(14) 18(26) 2.23 0.05 
Extra Pulmonary TB 15(13) 12(17) 0.70 0.52 
Has TB treatment Supporter 75(64) 50(73) 0.68 0.31 
Suffered serious illness 39(33) 31(45) 0.61 0.16 
On other chronic treatment 17(15) 16(23) 0.57 0.20 
Had CD4 test done 75(65) 61(88) 0.24 0.00 
Initially registered outside district 39(34) 10(14) 2.95 0.01 
Initially sought TB/HIV care outside public 
health sector 
69(59) 23(33) 2.88 0.001 
Distance to nearest clinic>5km 40(35) 9(13) 3.51 0.002 
Distance to ART site .10km 52(44) 23(33) 1.60 0.18 
Cost to ART initiation site>$1 59(50) 24(35) 1.91 0.005 













Figure 1: availability of HIV Care Services in Health Facilities, Sanyati, Zimbabwe, 2012 
 
 
 
 
